Ingunn Munch Lindvig
Consejero General en BIOINVENT INTERNATIONAL AB .
Cargos activos de Ingunn Munch Lindvig
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| BIOINVENT INTERNATIONAL AB | Consejero General | 12/06/2023 | - |
Historial de carrera de Ingunn Munch Lindvig
Antiguos cargos conocidos de Ingunn Munch Lindvig.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| THOR MEDICAL | Consejero General | - | - |
| CIRCIO HOLDING ASA | Consejero General | 01/01/2019 | - |
Formación de Ingunn Munch Lindvig.
| University of Oslo | Doctorate Degree |
Estadísticas
Internacional
| Noruega | 4 |
| Suecia | 2 |
Operativa
| General Counsel | 3 |
| Doctorate Degree | 1 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| CIRCIO HOLDING ASA | Health Technology |
| BIOINVENT INTERNATIONAL AB | Health Technology |
| Empresas privadas | 1 |
|---|---|
Nordic Nanovector ASA
 Nordic Nanovector ASA Pharmaceuticals: MajorHealth Technology Nordic Nanovector ASA is a biopharmaceutical company, which engages in the development, marketing, and sale of medical products and equipment for anticancer therapeutics for haematological cancers. The firm offers the Betalutin which is an antibody radionuclide conjugates for the treatment of non-Hodgkin lymphoma. It operates through the following geographical segments: Norway, Switzerland, and the United Kingdom. The company was founded by Roy Hartvig Larsen, Oyvind Sverre Bruland, and Jostein Dahle on July 2, 2009 and is headquartered in Oslo, Norway. | Health Technology |
- Bolsa de valores
- Insiders
- Ingunn Munch Lindvig
- Experiencia
